تحميل...
Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model
Intravenous (IV) topotecan is approved for the treatment of various malignancies including lung cancer but its clinical use is greatly undermined by severe hematopoietic toxicity. We hypothesized that inhalation delivery of topotecan would increase local exposure and efficacy against lung cancer whi...
محفوظ في:
| الحاوية / القاعدة: | Drug Deliv |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Taylor & Francis
2018
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058531/ https://ncbi.nlm.nih.gov/pubmed/29779406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1469688 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|